{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:54:10Z","timestamp":1767646450556,"version":"3.48.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82300982 and No. 82470921"],"award-info":[{"award-number":["No. 82300982 and No. 82470921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04483-6","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:37:08Z","timestamp":1767638228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["10-year cardiovascular disease risk and its contributing factors in primary hyperparathyroidism"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5524-507X","authenticated-orcid":false,"given":"Song-feng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-zhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-xi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2561-1468","authenticated-orcid":false,"given":"Min-ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0179-1751","authenticated-orcid":false,"given":"Jian-min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"3","key":"4483_CR1","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"M.W. Yeh, P.H. Ituarte, H.C. Zhou et al., Incidence and prevalence of primary hyperparathyroidism in a Racially mixed population. J. Clin. Endocrinol. Metab. 98(3), 1122\u20131129 (2013). doi:2019041114012496000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4483_CR2","doi-asserted-by":"publisher","first-page":"1083521","DOI":"10.3389\/fendo.2023.1083521","volume":"14","author":"R Chen","year":"2023","unstructured":"R. Chen, A. Song, O. Wang et al., The preliminary study on cardiac structure and function in Chinese patients with primary hyperparathyroidism. Front. Endocrinol. (Lausanne). 14, 1083521 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1083521","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4483_CR3","doi-asserted-by":"publisher","unstructured":"W. Thu, A. Hashmi, Atypical presentation of primary hyperparathyroidism. Cureus Published Online November. 24 (2024). https:\/\/doi.org\/10.7759\/cureus.74337","DOI":"10.7759\/cureus.74337"},{"key":"4483_CR4","doi-asserted-by":"publisher","first-page":"117130","DOI":"10.1016\/j.bone.2024.117130","volume":"185","author":"SK Kong","year":"2024","unstructured":"S.K. Kong, M.C. Tsai, C.L. Yeh et al., Association between primary hyperparathyroidism and cardiovascular outcomes: A systematic review and meta-analysis. Bone. 185, 117130 (2024). https:\/\/doi.org\/10.1016\/j.bone.2024.117130","journal-title":"Bone"},{"key":"4483_CR5","doi-asserted-by":"publisher","first-page":"692722","DOI":"10.3389\/fendo.2021.692722","volume":"12","author":"S Wang","year":"2021","unstructured":"S. Wang, Y. He, M. Zhu, ting et al., The associations of serum osteocalcin and cortisol levels with the psychological performance in primary hyperparathyroidism patients. Front. Endocrinol. 12, 692722 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.692722","journal-title":"Front. Endocrinol."},{"issue":"2","key":"4483_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1210\/jc.2012-2914","volume":"98","author":"L Zhao","year":"2013","unstructured":"L. Zhao, J.M. Liu, X.Y. He et al., The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J. Clin. Endocrinol. Metab. 98(2), 721\u2013728 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4483_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ebiom.2018.11.057","volume":"40","author":"Y He","year":"2019","unstructured":"Y. He, R.X. Liu, M.T. Zhu et al., The Browning of white adipose tissue and body weight loss in primary hyperparathyroidism. EBioMedicine. 40, 56\u201366 (2019). https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.057","journal-title":"EBioMedicine"},{"issue":"20","key":"4483_CR8","doi-asserted-by":"publisher","first-page":"e147116","DOI":"10.1172\/JCI147116","volume":"131","author":"L Santhanam","year":"2021","unstructured":"L. Santhanam, G. Liu, S. Jandu et al., Skeleton-secreted PDGF-BB mediates arterial stiffening. J. Clin. Invest. 131(20), e147116 (2021). https:\/\/doi.org\/10.1172\/JCI147116","journal-title":"J. Clin. Invest."},{"issue":"7","key":"4483_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tem.2024.02.005","volume":"35","author":"DA Towler","year":"2024","unstructured":"D.A. Towler, Parathyroid hormone\u2013PTH1R signaling in cardiovascular disease and homeostasis. Trends Endocrinol. Metabolism. 35(7), 648\u2013660 (2024). https:\/\/doi.org\/10.1016\/j.tem.2024.02.005","journal-title":"Trends Endocrinol. Metabolism"},{"issue":"1","key":"4483_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","volume":"19","author":"S Beysel","year":"2019","unstructured":"S. Beysel, M. Caliskan, M. Kizilgul et al., Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc. Disord. 19(1), 106 (2019). https:\/\/doi.org\/10.1186\/s12872-019-1093-4","journal-title":"BMC Cardiovasc. Disord"},{"issue":"3","key":"4483_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/ejendo\/lvae109","volume":"191","author":"A Heck","year":"2024","unstructured":"A. Heck, M. Pretorius, K. Lundstam et al., No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial. Eur. J. Endocrinol. 191(3), 354\u2013360 (2024). https:\/\/doi.org\/10.1093\/ejendo\/lvae109","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"4483_CR12","doi-asserted-by":"publisher","first-page":"e13589","DOI":"10.1111\/1753-0407.13589","volume":"16","author":"Q Li","year":"2024","unstructured":"Q. Li, Y. Song, Z. Zhang et al., The combined effect of triglyceride\u2013glucose index and high-sensitivity C \u2010reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study. J. Diabetes. 16(8), e13589 (2024). https:\/\/doi.org\/10.1111\/1753-0407.13589","journal-title":"J. Diabetes"},{"issue":"10","key":"4483_CR13","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1111\/1753-0407.70007","volume":"16","author":"X Jia","year":"2024","unstructured":"X. Jia, Y. Ding, C. Hu et al., The association of ideal cardiovascular health and its change with subclinical atherosclerosis according to glucose status: A prospective cohort study. J. Diabetes. 16(10), e70007 (2024). https:\/\/doi.org\/10.1111\/1753-0407.70007","journal-title":"J. Diabetes"},{"issue":"4","key":"4483_CR14","doi-asserted-by":"publisher","first-page":"e13530","DOI":"10.1111\/1753-0407.13530","volume":"16","author":"X Kong","year":"2024","unstructured":"X. Kong, R. Xie, D. Zhang et al., Association of cardiovascular disease prevalence with BMD and fracture in men with T2DM. J. Diabetes. 16(4), e13530 (2024). https:\/\/doi.org\/10.1111\/1753-0407.13530","journal-title":"J. Diabetes"},{"key":"4483_CR15","doi-asserted-by":"publisher","unstructured":"A.A. Khan, J.P. Bilezikian, M.L. Brandi et al., Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop. J Bone Miner Res. 2022;37(12):2568\u20132585. https:\/\/doi.org\/10.1002\/jbmr.4691","DOI":"10.1002\/jbmr.4691"},{"key":"4483_CR16","doi-asserted-by":"publisher","unstructured":"S.S. Virani, L.K. Newby, S.V. Arnold et al., 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: A report of the American heart Association\/American college of cardiology joint committee on clinical practice guidelines. Circulation. 148(9) (2023). https:\/\/doi.org\/10.1161\/CIR.0000000000001168","DOI":"10.1161\/CIR.0000000000001168"},{"key":"4483_CR17","doi-asserted-by":"publisher","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg et al., Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293\u20132314. https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"key":"4483_CR18","doi-asserted-by":"publisher","unstructured":"S.M. Grundy, N.J. Stone, A.L. Bailey, AHA\/ACC\/AACVPR\/AAPA NLA\/PCNA Guideline on the Management of Blood Cholesterol, A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 139(25) (2019). https:\/\/doi.org\/10.1161\/CIR.0000000000000625.","DOI":"10.1161\/CIR.0000000000000625"},{"issue":"1","key":"4483_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","volume":"73","author":"N Yu","year":"2010","unstructured":"N. Yu, P.T. Donnan, R.W. Flynn et al., Increased mortality and morbidity in mild primary hyperparathyroid patients. The parathyroid epidemiology and audit research study (PEARS). Clin. Endocrinol. (Oxf). 73(1), 30\u201334 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03766.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"8","key":"4483_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/jbmr.4631","volume":"37","author":"CL Robertson","year":"2020","unstructured":"C.L. Robertson, G. Ghosh, P. Fitzgerald et al., Bone turnover markers including undercarboxylated osteocalcin are associated with mortality risk in older men. J. Bone Miner. Res. 37(8), 1464\u20131472 (2020). https:\/\/doi.org\/10.1002\/jbmr.4631","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"4483_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/cen.12058","volume":"79","author":"B Tao","year":"2013","unstructured":"B. Tao, Z. Li, H.Y. Zhao et al., A lower value for quantitative ultrasound at radius is an additional indicator of metabolic syndrome and cardiovascular disease risk. Clin. Endocrinol. (Oxf). 79(3), 348\u2013355 (2013). https:\/\/doi.org\/10.1111\/cen.12058","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"5","key":"4483_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","volume":"7","author":"SG Wannamethee","year":"2014","unstructured":"S.G. Wannamethee, P. Welsh, O. Papacosta, L. Lennon, P.H. Whincup, N. Sattar, Elevated parathyroid Hormone, but not vitamin D Deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ: Heart Fail. 7(5), 732\u2013739 (2014). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001272","journal-title":"Circ: Heart Fail."},{"key":"4483_CR23","doi-asserted-by":"publisher","unstructured":"S. Wang, Y. He, M. Zhu, B. ting, Tao, H. Zhao, Sun L hao. The associations of serum osteocalcin and cortisol levels with the psychological performance in primary hyperparathyroidism patients. 2021;12(August):1\u20139. https:\/\/doi.org\/10.3389\/fendo.2021.692722","DOI":"10.3389\/fendo.2021.692722"},{"issue":"8","key":"4483_CR24","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1210\/clinem\/dgad078","volume":"108","author":"M Yang","year":"2023","unstructured":"M. Yang, J. Miao, L. Du et al., Serum calcium concentrations and risk of All-Cause and Cause-Specific mortality: results from 2 prospective cohorts. J. Clin. Endocrinol. Metab. 108(8), e527\u2013e535 (2023)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4483_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12020-013-0091-z","volume":"47","author":"M Procopio","year":"2014","unstructured":"M. Procopio, M. Barale, S. Bertaina et al., Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. 47(2), 581\u2013589 (2014). https:\/\/doi.org\/10.1007\/s12020-013-0091-z","journal-title":"Endocrine"},{"key":"4483_CR26","doi-asserted-by":"publisher","first-page":"1266728","DOI":"10.3389\/fendo.2023.1266728","volume":"14","author":"EA Dobreva","year":"2023","unstructured":"E.A. Dobreva, A.M. Gorbacheva, E.E. Bibik et al., Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience. Front. Endocrinol. (Lausanne). 14, 1266728 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1266728","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"24","key":"4483_CR27","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2021","unstructured":"L. Wang, W. Peng, Z. Zhao et al., Prevalence and treatment of diabetes in China, 2013\u20132018. JAMA 326(24), 2498 (2021). https:\/\/doi.org\/10.1001\/jama.2021.22208","journal-title":"JAMA"},{"key":"4483_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1464-5491.1991.tb01678.x","volume":"8","author":"WH Taylor","year":"1991","unstructured":"W.H. Taylor, The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives. Diabet. Med. 8, 683\u2013687 (1991). https:\/\/doi.org\/10.1111\/j.1464-5491.1991.tb01678.x","journal-title":"Diabet. Med."},{"key":"4483_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2362.1983.tb00116.x","volume":"13","author":"S LJUNGHALL MP G","year":"1983","unstructured":"S. LJUNGHALL MP G, AKERSTROM &L WIDE, Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur. J. Clinicul Incestigation. 13, 373\u2013377 (1983). https:\/\/doi.org\/10.1111\/j.1365-2362.1983.tb00116.x","journal-title":"Eur. J. Clinicul Incestigation"},{"issue":"8","key":"4483_CR30","doi-asserted-by":"publisher","first-page":"e13598","DOI":"10.1111\/1753-0407.13598","volume":"16","author":"F Chen","year":"2024","unstructured":"F. Chen, Y. He, J. Wang et al., Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long-term risk of cardiovascular events and mortality. J. Diabetes. 16(8), e13598 (2024). https:\/\/doi.org\/10.1111\/1753-0407.13598","journal-title":"J. Diabetes"},{"issue":"6","key":"4483_CR31","doi-asserted-by":"publisher","first-page":"e70099","DOI":"10.1111\/1753-0407.70099","volume":"17","author":"T Sarabhai","year":"2025","unstructured":"T. Sarabhai, K. Kostev, Time trends in cardiovascular event incidence in New-Onset type 2 diabetes: A Population\u2010Based cohort study from Germany. J. Diabetes. 17(6), e70099 (2025). https:\/\/doi.org\/10.1111\/1753-0407.70099","journal-title":"J. Diabetes"},{"issue":"2","key":"4483_CR32","doi-asserted-by":"publisher","first-page":"e13539","DOI":"10.1111\/1753-0407.13539","volume":"16","author":"R Chilton","year":"2024","unstructured":"R. Chilton, E.I. Iranpour, Z. Bloomgarden, Deciphering the connection: Diabetes, pericyte dysfunction, and their impact on cardiovascular health. J. Diabetes. 16(2), e13539 (2024). https:\/\/doi.org\/10.1111\/1753-0407.13539","journal-title":"J. Diabetes"},{"issue":"2","key":"4483_CR33","doi-asserted-by":"publisher","first-page":"e13493","DOI":"10.1111\/1753-0407.13493","volume":"16","author":"F Chen","year":"2024","unstructured":"F. Chen, L. Yu, S. Xie et al., Cardiovascular disease risk in early-onset vs late\u2010onset type 2 diabetes in china: A population\u2010based cross\u2010sectional study. J. Diabetes. 16(2), e13493 (2024). https:\/\/doi.org\/10.1111\/1753-0407.13493","journal-title":"J. Diabetes"},{"issue":"11","key":"4483_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.amjhyper.2004.06.016","volume":"17","author":"S Pierdomenico","year":"2004","unstructured":"S. Pierdomenico, D. Lapenna, A. Bucci, B. Manente, F. Cuccurullo, A. Mezzetti, Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension. Am. J. Hypertens. 17(11), 1035\u20131039 (2004). https:\/\/doi.org\/10.1016\/j.amjhyper.2004.06.016","journal-title":"Am. J. Hypertens."},{"key":"4483_CR35","doi-asserted-by":"publisher","unstructured":"N. Verheyen, A. Meinitzer, M.R. Gr\u00fcbler et al., Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial. Clin. Chem. Lab. Med. (CCLM). 55(7) (2017). https:\/\/doi.org\/10.1515\/cclm-2016-1159","DOI":"10.1515\/cclm-2016-1159"},{"issue":"5","key":"4483_CR36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/jcm11051373","volume":"11","author":"S Frey","year":"2022","unstructured":"S. Frey, R. Bourgade, Le C. May et al., Effect of parathyroidectomy on metabolic homeostasis in primary hyperparathyroidism. JCM. 11(5), 1373 (2022). https:\/\/doi.org\/10.3390\/jcm11051373","journal-title":"JCM"},{"key":"4483_CR37","doi-asserted-by":"publisher","unstructured":"X. Liu, D.T.W. Lui, X. Xiong et al., Parathyroidectomy and risk of incident diabetes in patients with primary hyperparathyroidism. JAMA Surg Published Online August. 27 (2025). https:\/\/doi.org\/10.1001\/jamasurg.2025.3081","DOI":"10.1001\/jamasurg.2025.3081"},{"issue":"6","key":"4483_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","volume":"13","author":"LL Schierbeck","year":"2011","unstructured":"L.L. Schierbeck, T.S. Jensen, U. Bang, G. Jensen, L. Kober, J.E. Jensen, Parathyroid hormone and vitamin D\u2013markers for cardiovascular and all cause mortality in heart failure. Eur. J. Heart Fail. 13(6), 626\u2013632 (2011). https:\/\/doi.org\/10.1093\/eurjhf\/hfr016","journal-title":"Eur. J. Heart Fail."},{"issue":"6694","key":"4483_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.adh7954","volume":"384","author":"E Giampazolias","year":"2024","unstructured":"E. Giampazolias, M. Pereira da Costa, K.C. Lam et al., Vitamin D regulates microbiome-dependent cancer immunity. Science. 384(6694), 428\u2013437 (2024). https:\/\/doi.org\/10.1126\/science.adh7954","journal-title":"Science"},{"issue":"11","key":"4483_CR40","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.2337\/dc20-1109","volume":"43","author":"M Wang","year":"2020","unstructured":"M. Wang, T. Zhou, X. Li et al., Baseline vitamin D Status, sleep Patterns, and the risk of incident type 2 diabetes in data from the UK biobank study. Diabetes Care. 43(11), 2776\u20132784 (2020). https:\/\/doi.org\/10.2337\/dc20-1109","journal-title":"Diabetes Care"},{"key":"4483_CR41","doi-asserted-by":"publisher","first-page":"e075230","DOI":"10.1136\/bmj-2023-075230","volume":"28","author":"B Thompson","year":"2023","unstructured":"B. Thompson, M. Waterhouse, D.R. English et al., Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ 28, e075230 (2023). https:\/\/doi.org\/10.1136\/bmj-2023-075230","journal-title":"BMJ Published Online June"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04483-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:37:08Z","timestamp":1767638228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04483-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04483-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Jian-min Liu is the associate editor of Endocrine and played no role in the Journal\u2019s evaluation of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"30"}}